George Medicines is a drug manufacturing company that improves the management of non-communicable diseases.
George Medicines has raised $1.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2022.
George Medicines's investors include Brandon Capital, Bupa, Brandon BioCatalyst, Medical Research Commercialisation Fund (MRCF).
George Medicines is headquartered in London, United Kingdom.
George Medicines is a drug manufacturing company that improves the management of non-communicable diseases.
George Medicines is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"George Medicines — Funding & Investors." VCBacked, July 20, 2022, https://www.vcbacked.co/company/george-medicines. Accessed September 30, 2026.
VCBacked. (2022). George Medicines — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/george-medicines
{{cite web |title=George Medicines — Funding & Investors |url=https://www.vcbacked.co/company/george-medicines |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated